| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.350 | 5.762 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 10.350 | 5.762 | 1.989 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 9.783 | 9.446 | 15.285 | 678 | - | 7 | 0 | 361 | 285 | 1.568 |
| Gross Profit/Loss - EUR | 567 | -3.684 | -13.295 | -678 | - | -7 | 0 | -361 | -285 | -1.568 |
| Net Profit/Loss - EUR | 257 | -3.741 | -13.355 | -678 | - | -7 | 0 | -361 | -285 | -1.568 |
| Employees | 3 | 4 | 1 | 0 | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Med-Angeli Srl-D
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.626 | 11.507 | 1.487 | 1.459 | - | 1.404 | 1.373 | 1.377 | 1.373 | 0 |
| Current Assets | 19.742 | 21.989 | 5.654 | 5.549 | - | 1.442 | 1.491 | 1.541 | 1.494 | 1.016 |
| Inventories | 9.518 | 9.711 | 1.144 | 1.123 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 10.059 | 12.114 | 4.491 | 4.409 | - | 1.435 | 1.484 | 1.489 | 1.484 | 1.000 |
| Cash | 165 | 165 | 19 | 17 | - | 7 | 7 | 52 | 9 | 16 |
| Shareholders Funds | 5.915 | 2.114 | -46.369 | -46.196 | - | -45.740 | -44.726 | -45.225 | -45.373 | -46.687 |
| Social Capital | 337 | 334 | 328 | 322 | - | 310 | 303 | 304 | 303 | 302 |
| Debts | 38.002 | 43.964 | 53.510 | 53.204 | - | 48.587 | 47.590 | 48.143 | 48.240 | 47.703 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1419 - 1419" | |||||||||
| CAEN Financial Year |
1419
|
|||||||||
Comments - Med-Angeli Srl-D